Oncolytics Biotech (ONCY) Change in Account Payables (2020 - 2021)
Oncolytics Biotech's (ONCY) quarterly Change in Account Payables came in at $2.3 million in Q3 2021, down 64.97% on a QoQ basis from $6.5 million in Q4 2020.
Oncolytics Biotech (ONCY) Change in Account Payables (2020 - 2021) Analysis & Trends
Oncolytics Biotech (ONCY) has 2 years of Change in Account Payables data on file, last reported at $2.3 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2.28 Mn |
| Sep 30, 2021 | 2.28 Mn |
| Dec 31, 2020 | 6.52 Mn |
| Dec 31, 2020 | 6.52 Mn |